193 related articles for article (PubMed ID: 1320533)
21. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
Damier P; Hirsch EC; Agid Y; Graybiel AM
Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
[TBL] [Abstract][Full Text] [Related]
22. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.
Gibb WR; Lees AJ
J Neurol Neurosurg Psychiatry; 1991 May; 54(5):388-96. PubMed ID: 1865199
[TBL] [Abstract][Full Text] [Related]
23. Chronic schizophrenia and idiopathic Parkinson's disease.
Lam RW
Can J Psychiatry; 1993 Mar; 38(2):75-7. PubMed ID: 8096793
[TBL] [Abstract][Full Text] [Related]
24. Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?
Ziv I; Offen D; Barzilai A; Haviv R; Stein R; Zilkha-Falb R; Shirvan A; Melamed E
J Neural Transm Suppl; 1997; 49():195-202. PubMed ID: 9266428
[TBL] [Abstract][Full Text] [Related]
25. GABA-dopamine relationship in Parkinson's disease striatum.
Kish S; Rajput A; Gilbert J; Rozdilsky B; Chang LJ; Shannak K; Hornykiewicz O
Adv Neurol; 1987; 45():75-7. PubMed ID: 3825737
[No Abstract] [Full Text] [Related]
26. Neuropathology of the substantia nigra.
Gibb WR
Eur Neurol; 1991; 31 Suppl 1():48-59. PubMed ID: 1830274
[TBL] [Abstract][Full Text] [Related]
27. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
Pifl C; Schingnitz G; Hornykiewicz O
Neurosci Lett; 1988 Oct; 92(2):228-33. PubMed ID: 3263594
[TBL] [Abstract][Full Text] [Related]
28. Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review.
Burns RS
Acta Neurol Scand Suppl; 1991; 136():29-36. PubMed ID: 1801534
[TBL] [Abstract][Full Text] [Related]
29. Striatonigral degeneration. A case report and a review of the literature.
van Leeuwen RB; Perquin WV
Clin Neurol Neurosurg; 1988; 90(2):121-4. PubMed ID: 3061696
[TBL] [Abstract][Full Text] [Related]
30. Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions.
Pehek EA; Crock R; Yamamoto BK
Synapse; 1992 Apr; 10(4):317-25. PubMed ID: 1374937
[TBL] [Abstract][Full Text] [Related]
31. The nigrostriatal system in Parkinson's disease.
Graybiel AM; Hirsch EC; Agid Y
Adv Neurol; 1990; 53():17-29. PubMed ID: 1978514
[TBL] [Abstract][Full Text] [Related]
32. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
33. Nigral degeneration in Parkinson's disease in relation to clinical features.
Rinne JO
Acta Neurol Scand Suppl; 1991; 136():87-90. PubMed ID: 1801543
[TBL] [Abstract][Full Text] [Related]
34. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease.
Sulzer D
Trends Neurosci; 2007 May; 30(5):244-50. PubMed ID: 17418429
[TBL] [Abstract][Full Text] [Related]
35. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease.
Ben-Shachar D; Eshel G; Riederer P; Youdim MB
Ann Neurol; 1992; 32 Suppl():S105-10. PubMed ID: 1510367
[TBL] [Abstract][Full Text] [Related]
36. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
37. [Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease].
Bertrand E; Lechowicz W; Szpak GM; Dymecki J
Neurol Neurochir Pol; 1997; 31(2):295-302. PubMed ID: 9380259
[TBL] [Abstract][Full Text] [Related]
38. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
Love S; Wilcock GK; Matthews SM
Acta Neuropathol; 1996; 91(4):432-6. PubMed ID: 8928622
[TBL] [Abstract][Full Text] [Related]
39. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
Jenner P
Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254
[TBL] [Abstract][Full Text] [Related]
40. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
